Articles published by Onc.AI

Onc.AI Announces Positive External Validation of Onclara IO, a CT Imaging AI Biomarker for First-Line Immunotherapy in PD-L1-High Metastatic Non-Small Cell Lung Cancer

Today 7:00 EDT

From Onc.AI

Via Business Wire

Onc.AI to Present Breakthrough Deep Learning Radiomic Biomarker Results at 2025 ASCO Annual Meeting

May 30, 2025

From Onc.AI

Via Business Wire

Onc.AI Announces Presentation of Breakthrough-Designated AI Model Evaluated in Clinical Trial Data at AACR 2025

April 25, 2025

From Onc.AI

Via Business Wire

Onc.AI Awarded FDA Breakthrough Device Designation for Serial CT Response Score Deep Learning Model

February 06, 2025

From Onc.AI

Via Business Wire

Onc.AI Serial Imaging Response Score Outperforms Traditional Methods for Early Assessment of NSCLC Immunotherapy Outcomes

November 06, 2024

From Onc.AI

Via Business Wire

Onc.AI Awarded $2 Million National Cancer Institute Grant to Advance AI-based Clinical Decision Support for Metastatic NSCLC

October 24, 2024

From Onc.AI

Via Business Wire

Onc.AI to Present Collaboration Results Demonstrating Immunotherapy Response Prediction Using a Radiomic Signature in Late-Stage Lung Cancer

May 30, 2024

From Onc.AI

Via Business Wire

Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital

January 05, 2023

From Onc.AI

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.